As the third most common malignancy and the second most deadly cancer, colorectal
cancer (CRC) induces estimated 1.9 million incidence cases and 0.9 million deaths …

Background The consensus molecular subtypes (CMSs) of colorectal cancer (CRC) capture
tumor heterogeneity at the gene-expression level. Currently, a restricted number of …

Long noncoding RNAs (lncRNAs) are recently implicated in modifying immunology in
colorectal cancer (CRC). Nevertheless, the clinical significance of immune-related lncRNAs …

Background Head and neck squamous cell carcinoma (HNSCC) is the most common head
and neck cancer and is highly aggressive and heterogeneous, leading to variable prognosis …

Background: Clear cell renal cell carcinoma (ccRCC) accounts for 80% of all kidney cancers
and has a poor prognosis. Recent studies have shown that copper-dependent, regulated …

The signature composed of immune-related long noncoding ribonucleic acids (irlncRNAs)
with no requirement of specific expression level seems to be valuable in predicting the …

In terms of mortality and survival, pancreatic cancer is one of the worst malignancies. Known
as a unique type of programmed cell death, cuprotosis contributes to tumor cell growth …

Summary Background Long non-coding RNAs (lncRNAs) have recently emerged as
essential biomarkers of cancer progression. However, studies are limited regarding …

Background Uveal melanoma (UVM) is the most common primary intraocular malignancy in
adults and is highly metastatic, resulting in a poor patient prognosis. Sphingolipid …

Background Lung adenocarcinoma (LUAD) is a heterogeneous disease with a dismal
prognosis for advanced tumors. Immune-associated cells in the microenvironment …